申请人:Biolipox AB
公开号:EP2258689A1
公开(公告)日:2010-12-08
The present invention is directed to a method for reducing the emetogenic effects of PDE inhibitors, and more particularly is directed to compounds having PDE4 inhibition activity with little or no emetogenic side-effects, and chemical methods including benzylation for preparing such compounds. A benzyl group may be attached to either a carbon or nitrogen atom of a PDE4 inhibitor. Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, and then react the resulting nucleophilic PDE4 inhibitor with a benzylating agent, e.g., benzyl bromide or a derivative thereof.
本发明涉及一种减少PDE抑制剂致呕吐作用的方法,更具体地说,本发明涉及具有PDE4抑制活性而很少或没有致呕吐副作用的化合物,以及制备这种化合物的包括苄基化的化学方法。苄基可以连接到 PDE4 抑制剂的碳原子或氮原子上。合适的苄化化学方法是从 PDE4 抑制剂中提取一个氢,最好是用碱,然后将得到的亲核 PDE4 抑制剂与苄化剂(如溴化苄或其衍生物)反应。